Status:
COMPLETED
Neuroendocrine Dysfunction in Critically Ill Pediatric Patients
Lead Sponsor:
Children's Healthcare of Atlanta
Conditions:
Critical Illness
Eligibility:
All Genders
5+ years
Brief Summary
Research studies in adults have shown that certain hormones may be decreased or may not work normally which contributes to how sick a person becomes. The purpose of this project is to study hormones i...
Detailed Description
Neuroendocrine dysfunction is an abnormality in the production or release of certain hormones. Studies completed in adult patients have shown abnormal hormone levels in critical illness can contribute...
Eligibility Criteria
Inclusion
- All patients, birth - 18 years of age
- Admitted to the pediatric intensive care unit requiring blood to be drawn as part of medical management consistent with "standard of care".
Exclusion
- Elective post-operative surgical patients.
- Pre-existing/known neuroendocrine disorder including, but not limited to, disorders of the hypothalamus, pituitary, adrenal, or thyroid gland.
- Patients being treated with or having a recent history of taking anti-psychotic medications (e.g. ingestion).
- Patients whose laboratory specimens have already been drawn prior to admission (emergency room or another facility) and who do not require further blood draws for medical management within a 12 hour window.
Key Trial Info
Start Date :
August 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT00207896
Start Date
August 1 2004
End Date
August 1 2007
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States, 30322